RxDoctor Payments Data

Tyler Bonkowski

Cardiovascular Disease · Dearborn, MINPI 1174185904

Payments from drug & device makers

$11,670in general payments, 2019–2025

Across 140 payments — averaging $83.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eko Health, Inc.$3K
  • Abbott$2K
  • ZOLL Circulation Inc$2K
  • AstraZeneca$918
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$813
  • Cardiva Medical, Inc.$398
  • plus $3K from 22 others

What the payments were for

  • Speaking & faculty fees$1,90016%
  • Travel & lodging$2,60122%
  • Food & beverage$5,89651%
  • Education$4444%
  • Other$8287%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,670 in reported general payments places this provider in the 70th percentile of 760 cardiovascular disease providers in Michigan.

See all cardiovascular disease providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban36$31,354
EntrestoSacubitril/Valsartan11$16,780
Atorvastatin Calcium41$662
Metoprolol Succinate36$505
Losartan Potassium33$329
Carvedilol30$266
Rosuvastatin Calcium16$238
ClopidogrelClopidogrel Bisulfate18$217

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$70$31,35436 claims
NovartisEntresto$41$16,78011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 760 cardiovascular disease providers in Michigan.

Other cardiovascular disease in Dearborn

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →